| 1 |
27339904 | Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells. | 2016 Sep 6 |
2 |
| 2 |
17136320 | Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction. | 2007 Jan |
4 |
| 3 |
16950207 | Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. | 2006 Nov 15 |
3 |
| 4 |
15946692 | Sulindac activates nuclear translocation of AIF, DFF40 and endonuclease G but not induces oligonucleosomal DNA fragmentation in HT-29 cells. | 2005 Sep 2 |
1 |
| 5 |
16273229 | Differential gene expression of sulindac-treated human breast epithelial cells. | 2005 Dec |
3 |
| 6 |
11912124 | Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). | 2002 Mar 15 |
2 |
| 7 |
9192825 | Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. | 1997 Jun 15 |
2 |
| 8 |
8526349 | Molecular markers in chemoprevention of colon cancer. Inhibition of expression of ras-p21 and p53 by sulindac during azoxymethane-induced colon carcinogenesis. | 1995 Sep 30 |
1 |